La bourse est fermée
  • CAC 40

    5 598,18
    +31,39 (+0,56 %)
  • Euro Stoxx 50

    3 527,79
    +16,85 (+0,48 %)
  • Dow Jones

    29 910,37
    +37,90 (+0,13 %)

    +0,0057 (+0,48 %)
  • Gold future

    1 788,10
    -23,10 (-1,28 %)

    15 133,36
    +281,79 (+1,90 %)
  • CMC Crypto 200

    -4,23 (-1,25 %)
  • Pétrole WTI

    -0,18 (-0,39 %)
  • DAX

    13 335,68
    +49,11 (+0,37 %)
  • FTSE 100

    6 367,58
    +4,65 (+0,07 %)
  • Nasdaq

    12 205,85
    +111,44 (+0,92 %)
  • S&P 500

    3 638,35
    +8,70 (+0,24 %)
  • Nikkei 225

    26 644,71
    +107,40 (+0,40 %)

    26 894,68
    +75,23 (+0,28 %)

    -0,0042 (-0,32 %)

Global Biliary Stents Markets

·4 min de lecture

Report Scope: This report covers a range of products, some of which are disease-specific and others that are more often used across all types of patients and in general for health management.

New York, Nov. 09, 2020 (GLOBE NEWSWIRE) -- announces the release of the report "Global Biliary Stents Markets" -
The market for biliary stents referred to in the report is limited to the devices/products included in this report.

The study will enable its readers to understand and gain insights into the current market, and it will also forecast the changing market scenario. The data provided can help industry players understand which market segments (products) are expected to grow at higher rates, which factors are driving growth, which factors are limiting growth, what the key opportunity areas are and so on.

Discussion and analysis cover the following market factors -
- Key market analysis.
- Market dynamics (trends, drivers and restraints).
- Market forecast period of 2020 through 2025.
- Competitive developments and landscape.
- Geographic regional analysis.
- Regulatory scenario in major countries and regions

The report also provides a detailed competitive outlook, including the market share and company profiles of the key participants operating in the global market.Key players profiled in the report include Medtronic plc, Cook Medical, C.

R. Bard (subsidiary of BD), Abbott, Boston Scientific, Edward Lifesciences, CONMED, Taewong Medical, Allium Medical Solutions, Changzhou Health Microport Medical Devices, Dispomedica, Innovex Medical, Medinol, Merit Medical Systems, Medi-Globe, OptiMed, M.I Tech, Endotec Oy, Meditek Systems, ELLA - CS, s.r.o., Endocor GMBH, ENDOTECH, Leufen Medical, and Luda Medica, etc.

Report Includes:
- 22 data tables and 41 additional tables
- A brief overview of the global markets for biliary stents within the medical devices industry
- Analyses of the global market trends, with corresponding market analysis data for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Estimation of the current and potential market size for biliary stents, market forecast and market share analysis on the basis of material type and geographical region
- Country specific data and analysis of the United States, Canada, Mexico, France, Germany, Italy, Spain, UK, Japan, China, India, Australia, South Korea and other emerging economies
- Insight into the factors driving and restraining the growth of global biliary stents market, along with market overviews covering manufacturing process, value chain process and pricing analysis
- Competitive landscape and key marketing strategies in biliary stents marketplace, including mergers and acquisition deals, partnerships, agreements, collaborations and joint ventures
- Detailed company profiles of major market players, including Abbott, Boston Scientific, Medtronic plc, Edward Lifesciences, CONMED and Changzhou Health Microport Medical Devices

Biliary stents are small plastic or metal tubes that are shaped like a blood vessel and used to open a passage between two hollow spaces in the body.This type of stent is an implantable device made up of materials such as nitinol, silicone and cobalt-chromium alloys.

They are designed to maintain the patency of stenotic vessels. These particular stents are often used to make a pathway in a bile duct to prevent any kind of blockages or obstructions to bodily fluid, and they also enable the transfer of air in obstructed natural circulatory pathways; in addition, they can be used to treat palliative-stage cancers, strictures and other medical conditions.

Different products have different competitive scenarios in the global market for biliary stents, which is fragmented yet consolidated.This market is unevenly penetrated, with different stents at different stages of their product life cycle with varying degrees of market penetration across the various regions.

A few market players hold a dominant market share, while the rest of the market is fragmented, with both national and global players. Biliary stents such as metal stents, plastic stents and biodegradable stents that are specialized for diseases or patient conditions represent some of the key opportunity areas that hold moderate growth potential for future growth of the market for biliary stents.

Some of the key growth strategies adopted by market players include collaborations and partnerships, product launches, and mergers and acquisitions, with product launches being the topmost strategy used to increase a company’s market presence as well as its share.

The high rate of adoption of minimally invasive biliary stents has boosted market growth. The development of advanced metal stents, bioabsorbable stents, magnetic stents and anti-reflux stents will drive the market during the forecast period.

The market for biliary stents is a highly competitive market involving many public as well as regional and local companies. To assure and sustain profitability, these players must constantly differentiate themselves in terms of both costs and products, and they must practice continuous product development and upgrades.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001